Amoxicillin shortages in French primary care: a qualitative study of family physicians' behaviors and infectious diseases implications - 19/11/26

Abstract |
Introduction |
Amoxicillin is the first-line antibiotic most commonly prescribed by family physicians (FPs) in France, but recurrent national shortages have disrupted its availability since 2013. Data on FPs' adaptations to these shortages, and their infectious disease consequences, remain scarce.
Patients and methods |
We conducted a qualitative study among 10 FPs practicing in the Hauts-de-Seine and Yvelines departments (France), using semi-structured interviews analyzed with Thomas's general inductive approach.
Results |
FPs described a triple uncertainty (drug availability, therapeutic choice, information) which prompted pragmatic prescribing, therapeutic substitution, and reliance on decision-support tools. Shortages reconfigured the physician-pharmacist-patient relation, empowering pharmacists while constraining patients. Substitution toward broader-spectrum antibiotics raised concerns about bacterial resistance, echoed by emerging clinical signals of complicated infections during shortage periods.
Conclusion |
Structured, real-time information and antimicrobial stewardship-compatible guidance are needed to anticipate future amoxicillin shortages in primary care.
Le texte complet de cet article est disponible en PDF.Highlights |
• | Family physicians (FPs) of the present study faced a triple uncertainty: drug availability, therapeutic choice, and information. |
• | Amoxicillin shortages drove pragmatic prescribing and broader-spectrum substitution. |
• | Shortages reconfigured physician-pharmacist-patient roles without institutional support. |
• | Broader-spectrum substitution raises concerns for resistance and clinical outcomes. |
• | Real-time alerts and stewardship-compatible guidance are needed for future shortages. |
Keywords : Amoxicillin, Drug shortage, Primary care, Prescribing behavior, Antimicrobial stewardship
Plan
Vol 56 - N° 8
Article 105371- novembre 2026 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
